Recombinant TNFRSF9 (Urelumab Biosimilar) antibody

Catalog No. ABIN7598076

This Human Monoclonal antibody specifically detects TNFRSF9 (Urelumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant TNFRSF9 (Urelumab Biosimilar) antibody (ABIN7598076)

Target: TNFRSF9 (Urelumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFRSF9 (Urelumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-TNFRSF9 (Urelumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Urelumab Biosimilar Antibody

Specificity: Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.29 mg/mL

Buffer: 0.94 mM Citric acid monohydrate, 16.7 mM Trisodium citrate dihydrate, 6.2 %  sucrose, pH  6.5, 0.01 % Tween 80.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for TNFRSF9 (Urelumab Biosimilar)

Target: TNFRSF9 (Urelumab Biosimilar)

Alternative Name: Urelumab Biosimilar

Target Type: Biosimilar

Background: Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA

UniProt: Q07011

CAS-No: 934823-49-1